UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2004 DELCATH SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 001-16133 06-1245881 (State or other (Commission File Number) (IRS Employer jurisdiction of Identification No.) incorporation) 1100 Summer Street, Stamford, Connecticut 06905 (Address of principal executive offices and zip code) Registrant's telephone number, including area code: (203) 323-8668 N/A (Former name or former address, if changes since last report) 2 Item 5. Other Events and Regulation FD Disclosure On January 26, 2004, Delicate Systems, Inc. (the "Company") issued a press release announcing an update on the experience of the National Cancer Institute using the Company's system for isolated liver perfusion. The Company's press release dated January 26, 2004 is incorporated herein by reference and filed as an exhibit hereto. Item 7. Financial Statements and Exhibits. (a) Not applicable (b) Not applicable. (c) Exhibits: Exhibit Description 99 Press Release dated January 26, 2004 of Delcath Systems, Inc. 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DELCATH SYSTEMS, INC. By: /s/ M. S. KOLY ------------------------------------- M. S. Koly President and Chief Executive Officer Date: January 26, 2004 EXHIBIT INDEX Exhibit Description 99 Press Release dated January 26, 2004 of Delcath Systems, Inc.